English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Mutations of the mitochondrial carrier translocase channel subunit TIM22 cause early-onset mitochondrial myopathy.

Pacheu-Grau, D., Callegari, S., Emperador, S., Thompson, K., Aich, A., Topol, S. E., et al. (2018). Mutations of the mitochondrial carrier translocase channel subunit TIM22 cause early-onset mitochondrial myopathy. Human Molecular Genetics, 27(23), 4135-4144. doi:10.1093/hmg/ddy305.

Item is

Basic

show hide
Item Permalink: http://hdl.handle.net/21.11116/0000-0002-84F0-9 Version Permalink: http://hdl.handle.net/21.11116/0000-0003-AF2A-A
Genre: Journal Article

Files

show Files
hide Files
:
3009561.pdf (Publisher version), 7MB
Name:
3009561.pdf
Description:
-
Visibility:
Public
MIME-Type / Checksum:
application/pdf / [MD5]
Technical Metadata:
Copyright Date:
-
Copyright Info:
-

Locators

show

Creators

show
hide
 Creators:
Pacheu-Grau, D., Author
Callegari, S., Author
Emperador, S., Author
Thompson, K., Author
Aich, A., Author
Topol, S. E., Author
Spencer, E. G., Author
McFarland, R., Author
Ruiz-Pesini, E., Author
Torkamani, A., Author
Taylor, R. W., Author
Montoya, J., Author
Rehling, P.1, Author              
Affiliations:
1Max Planck Fellow Peter Rehling, ou_1298545              

Content

show
hide
Free keywords: -
 Abstract: Protein import into mitochondria is facilitated by translocases within the outer and the inner mitochondrial membranes that are dedicated to a highly specific subset of client proteins. The mitochondrial carrier translocase (TIM22 complex) inserts multispanning proteins, such as mitochondrial metabolite carriers and translocase subunits (TIM23, TIM17A/B and TIM22), into the inner mitochondrial membrane. Both types of substrates are essential for mitochondrial metabolic function and biogenesis. Here, we report on a subject, diagnosed at 1.5 years, with a neuromuscular presentation, comprising hypotonia, gastroesophageal reflux disease and persistently elevated serum and Cerebrospinal fluid lactate (CSF). Patient fibroblasts displayed reduced oxidative capacity and altered mitochondrial morphology. Using trans-mitochondrial cybrid cell lines, we excluded a candidate variant in mitochondrial DNA as causative of these effects. Whole-exome sequencing identified compound heterozygous variants in the TIM22 gene (NM_013337), resulting in premature truncation in one allele (p.Tyr25Ter) and a point mutation in a conserved residue (p.Val33Leu), within the intermembrane space region, of the TIM22 protein in the second allele. Although mRNA transcripts of TIM22 were elevated, biochemical analyses revealed lower levels of TIM22 protein and an even greater deficiency of TIM22 complex formation. In agreement with a defect in carrier translocase function, carrier protein amounts in the inner membrane were found to be reduced. This is the first report of pathogenic variants in the TIM22 pore-forming subunit of the carrier translocase affecting the biogenesis of inner mitochondrial membrane proteins critical for metabolite exchange.

Details

show
hide
Language(s): eng - English
 Dates: 2018-08-242018-12-01
 Publication Status: Published in print
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Method: Peer
 Identifiers: DOI: 10.1093/hmg/ddy305
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Human Molecular Genetics
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 27 (23) Sequence Number: - Start / End Page: 4135 - 4144 Identifier: -